Clinically Used Radiolabeled Catecholamine Analogs
Tracer | Uptake-1 affinity | Vesicular storage | MAO/COMT-sensitive | General characteristics |
123I-MIBG | ++ | + | – | Catecholamine analog; distributes in cytoplasm and vesicles after neuronal uptake |
11C-HED | ++ | O | – | Catecholamine analog; undergoes constant uptake and reuptake by NET |
11C-EPI | + | ++ | + | Physiologic neurotransmitter; requires vesicular storage for protection from degradation |
11C-PHEN | + | + | + | Catecholamine analog; washout reflects vesicular leakage and MAO activity |
18F-FDA | + | ++ | + | Precursor of physiologic neurotransmitter; requires enzymatic conversion and vesicular storage for protection from degradation |
18F-LMI1195 | ? | ? | ? | Guanidine analog in phase 1 and 2 clinical studies; published information is limited |
COMT = catecholamine-O-methyl-transferase; HED = hydroxyephedrine; NET = norepinephrine transporter; EPI = epinephrine; PHEN = phenylephrine; FDA = fluorodopamine.